Anticancer Effect of AntiMalarial Artemisinin Compounds

Area of Science:

• Pharmacology
• Oncology
• Drug Discovery

Background:

• Artemisinin, an anti-malarial, demonstrates anticancer activity in preclinical studies.
• Limited clinical data exists for artemisinin's efficacy in human cancers.
• Antimalarial drugs possess biological characteristics conducive to anticancer properties.

Purpose of the Study:

• To explore the anticancer potential of artemisinin and its derivatives.
• To investigate the molecular mechanisms underlying artemisinin's anti-tumor effects.
• To evaluate artemisinins as a therapeutic alternative for aggressive cancers.

Main Methods:

• Literature review of PubMed (127 papers) on antimalarial anti-cancer effects.
• Analysis of experimental evidence on artemisinin compounds' efficacy.
• Examination of molecular mechanisms including apoptosis, cell cycle arrest, and oxidative stress.

Main Results:

• Semisynthetic artemisinin derivatives show enhanced antitumor activity compared to monomeric forms.
• Artemisinins induce apoptosis, G0/G1 cell cycle arrest, and oxidative stress.
• Artemisinins modulate key factors like NF-κB, survivin, NOXA, HIF-1α, and BMI-1.

Conclusions:

• Artemisinins may offer a therapeutic alternative for aggressive, rapidly disseminating cancers.
• Artemisinins exhibit synergistic effects with other anticancer drugs without increased normal cell toxicity.
• Further research is needed to elucidate exact mechanisms and validate synthetic derivatives in various cancer types.